Latest News

Common multiple sclerosis drugs taken together do not reduce relapse risk

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.
View full story

Post your comment.


  • Amblyopia, not strabismus, identified as key contributor to slow reading in school-age children

  • Visual stress could be a symptom of Chronic Fatigue Syndrome, research suggests

  • Lower availability of omega-3 fatty acids in the body associated with bipolar disorder

  • Rats: Sniff and track, or run and scan?

  • Two-thirds of studies on 'psychosocial' treatments fail to declare conflicts of interest

  • New protein biomarker identifies damaged brain wiring after concussion

  • Fruit flies provide new insight into body's rhythms

  • High-fat diet prompts immune cells to start eating connections between neurons

  • Want to remember new names? Sleep on it

  • Adults aged 50-59 now largest age group in opioid treatment programs